Iovance Biotherapeutics, Inc. (IOVA)
USD 2.8
(-6.83%)
USD 2.8
(-6.83%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -427.43 Million USD | -7.16% |
| 2022 | -374.75 Million USD | -16.39% |
| 2021 | -328.27 Million USD | -31.41% |
| 2020 | -250.86 Million USD | -26.07% |
| 2019 | -189.43 Million USD | -61.29% |
| 2018 | -122.62 Million USD | -38.09% |
| 2017 | -91.11 Million USD | -73.15% |
| 2016 | -51.91 Million USD | -92.53% |
| 2015 | -26.66 Million USD | -133.1% |
| 2014 | -11.94 Million USD | 47.19% |
| 2013 | -24.92 Million USD | -137.83% |
| 2012 | 508.81 Thousand USD | 42.57% |
| 2011 | -20.53 Million USD | -46441.53% |
| 2010 | -1.54 Million USD | 347.64% |
| 2009 | -14.44 Thousand USD | 74.13% |
| 2008 | -55.8 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -107.81 Million USD | 0.56% |
| 2024 Q2 | -91.05 Million USD | 15.55% |
| 2023 Q3 | -118.36 Million USD | -7.52% |
| 2023 FY | - USD | -7.16% |
| 2023 Q1 | -110.85 Million USD | -3.57% |
| 2023 Q2 | -110.08 Million USD | 0.69% |
| 2023 Q4 | -111.54 Million USD | 5.76% |
| 2022 Q3 | -100.39 Million USD | -6.25% |
| 2022 FY | - USD | -16.39% |
| 2022 Q1 | -86.73 Million USD | 12.8% |
| 2022 Q2 | -94.48 Million USD | -8.94% |
| 2022 Q4 | -107.03 Million USD | -6.61% |
| 2021 Q3 | -85.21 Million USD | -5.12% |
| 2021 Q4 | -99.46 Million USD | -16.72% |
| 2021 FY | - USD | -31.41% |
| 2021 Q1 | -75.19 Million USD | -10.24% |
| 2021 Q2 | -81.06 Million USD | -7.8% |
| 2020 FY | - USD | -26.07% |
| 2020 Q4 | -68.21 Million USD | -15.68% |
| 2020 Q2 | -63.36 Million USD | 10.19% |
| 2020 Q1 | -70.55 Million USD | -8.37% |
| 2020 Q3 | -58.96 Million USD | 6.95% |
| 2019 Q3 | -51.29 Million USD | -2.85% |
| 2019 Q2 | -49.87 Million USD | -25.58% |
| 2019 Q4 | -65.11 Million USD | -26.93% |
| 2019 FY | - USD | -61.29% |
| 2019 Q1 | -39.71 Million USD | -13.66% |
| 2018 Q2 | -31.37 Million USD | -17.75% |
| 2018 FY | - USD | -38.09% |
| 2018 Q4 | -34.94 Million USD | -0.38% |
| 2018 Q3 | -34.8 Million USD | -10.93% |
| 2018 Q1 | -26.64 Million USD | -2.22% |
| 2017 FY | - USD | -73.15% |
| 2017 Q1 | -20.88 Million USD | -31.14% |
| 2017 Q2 | -23.33 Million USD | -11.76% |
| 2017 Q3 | -22.34 Million USD | 4.26% |
| 2017 Q4 | -26.07 Million USD | -16.69% |
| 2016 Q3 | -18.83 Million USD | -64.38% |
| 2016 Q2 | -11.45 Million USD | -69.95% |
| 2016 Q1 | -6.74 Million USD | 25.38% |
| 2016 Q4 | -15.92 Million USD | 15.44% |
| 2016 FY | - USD | -92.53% |
| 2015 FY | - USD | -133.1% |
| 2015 Q4 | -9.03 Million USD | -22.45% |
| 2015 Q3 | -7.37 Million USD | -18.99% |
| 2015 Q2 | -6.2 Million USD | -21.27% |
| 2015 Q1 | -5.11 Million USD | -6.45% |
| 2014 Q4 | -4.8 Million USD | -71.68% |
| 2014 Q3 | -2.79 Million USD | -32.64% |
| 2014 Q2 | -2.1 Million USD | 5.97% |
| 2014 Q1 | -2.24 Million USD | 80.49% |
| 2014 FY | - USD | 47.19% |
| 2013 Q1 | -702.95 Thousand USD | 66.5% |
| 2013 Q2 | -1.02 Million USD | -46.26% |
| 2013 Q3 | -9.4 Million USD | -815.01% |
| 2013 Q4 | -11.49 Million USD | -22.2% |
| 2013 FY | - USD | -137.83% |
| 2012 Q4 | -2.09 Million USD | 2.01% |
| 2012 Q3 | -2.14 Million USD | 30.36% |
| 2012 FY | - USD | 42.57% |
| 2012 Q2 | -3.07 Million USD | -424.26% |
| 2012 Q1 | -586.5 Thousand USD | -421.71% |
| 2011 Q4 | 182.3 Thousand USD | 103.13% |
| 2011 Q1 | -734.08 Thousand USD | -282.37% |
| 2011 Q2 | -10.14 Million USD | -1281.85% |
| 2011 Q3 | -5.82 Million USD | 42.6% |
| 2011 FY | - USD | -46441.53% |
| 2010 Q1 | -67.68 Thousand USD | -3263.82% |
| 2010 FY | - USD | 347.64% |
| 2010 Q4 | -191.98 Thousand USD | -150.54% |
| 2010 Q3 | 379.87 Thousand USD | 548.87% |
| 2010 Q2 | -84.62 Thousand USD | -25.04% |
| 2009 Q1 | -6279.00 USD | 55.17% |
| 2009 Q2 | -3012.00 USD | 52.03% |
| 2009 Q3 | -3137.00 USD | -4.15% |
| 2009 Q4 | -2012.00 USD | 35.86% |
| 2009 FY | - USD | 74.13% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | -14 Thousand USD | -555.05% |
| 2008 Q1 | -24.96 Thousand USD | 0.0% |
| 2008 Q2 | -14.7 Thousand USD | 41.1% |
| 2008 Q3 | -2138.00 USD | 85.46% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -122.438% |
| Alkermes plc | 495.04 Million USD | 186.341% |
| Agenus Inc. | -145.92 Million USD | -192.914% |
| Aptorum Group Limited | -9.59 Million USD | -4352.882% |
| Ardelyx, Inc. | -55.35 Million USD | -672.179% |
| Dyadic International, Inc. | -8.22 Million USD | -5093.749% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -146783.849% |
| Lantern Pharma Inc. | -15.78 Million USD | -2607.547% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2046.563% |
| Novavax, Inc. | -487.39 Million USD | 12.302% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -501.813% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -444.548% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2278.13% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4188.042% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -644.967% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -12.491% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1672.702% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 80900.0% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -171.912% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -471.32% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2020.304% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1700.851% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1753.725% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -250.059% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -65.516% |
| AlloVir, Inc. | -190.14 Million USD | -124.791% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -143.313% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1360.906% |
| Bicycle Therapeutics plc | -183.4 Million USD | -133.06% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -158.39% |
| ChromaDex Corporation | -3.89 Million USD | -10876.682% |
| Chimerix, Inc. | -92.97 Million USD | -359.733% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -861.89% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -279.825% |
| CRISPR Therapeutics AG | -202.7 Million USD | -110.868% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1233.974% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -148.177% |
| Fortress Biotech, Inc. | -133.64 Million USD | -219.831% |
| Fortress Biotech, Inc. | -133.64 Million USD | -219.831% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -452.645% |
| ImmuCell Corporation | -2.5 Million USD | -16969.443% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -227.732% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2548.992% |
| Incyte Corporation | 919.42 Million USD | 146.489% |
| Innoviva, Inc. | 248.96 Million USD | 271.687% |
| IO Biotech, Inc. | -91.22 Million USD | -368.532% |
| Jaguar Health, Inc. | -33.13 Million USD | -1190.127% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -180.878% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 520.176% |
| ContextLogic Inc. | -324 Million USD | -31.923% |
| MiMedx Group, Inc. | 40.51 Million USD | 1154.945% |
| MEI Pharma, Inc. | 26.38 Million USD | 1720.288% |
| NextCure, Inc. | -59.03 Million USD | -623.982% |
| Onconetix, Inc. | -36.7 Million USD | -1064.451% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 19224.474% |
| Opthea Limited | -200.01 Million USD | -113.696% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -15434.057% |
| Vaxcyte, Inc. | -464.88 Million USD | 8.056% |
| PDS Biotechnology Corporation | -40.08 Million USD | -966.315% |
| Precigen, Inc. | -89.22 Million USD | -379.044% |
| Pharming Group N.V. | 9.87 Million USD | 4427.549% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -168.742% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1777.831% |
| PureTech Health plc | -11.62 Million USD | -3576.202% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2417.119% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -83.057% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1672.702% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -388.902% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1375.786% |
| Acelyrin, Inc. | -381.52 Million USD | -12.032% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3317211.983% |
| Summit Therapeutics Inc. | 1 Million USD | 42800.5% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1180.273% |
| Senti Biosciences, Inc. | -61.33 Million USD | -596.87% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -280.603% |
| Elevation Oncology, Inc. | -41.46 Million USD | -930.776% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1283.096% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -6888.127% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -133056.386% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1217.08% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -4990.9% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -627.049% |
| Seer, Inc. | -97.88 Million USD | -336.668% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -587.223% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -553.916% |
| ESSA Pharma Inc. | -26.45 Million USD | -1515.676% |
| GlycoMimetics, Inc. | -39.12 Million USD | -992.562% |
| GT Biopharma, Inc. | 5.97 Million USD | 7248.888% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -106.796% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -6123.529% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 592.365% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -653.131% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -734.518% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4223.213% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 20.835% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -6109.064% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -812.108% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -80.639% |
| Aptose Biosciences Inc. | -52.26 Million USD | -717.77% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -296.713% |
| Soligenix, Inc. | -7.85 Million USD | -5343.018% |
| Century Therapeutics, Inc. | -121.2 Million USD | -252.643% |
| Kura Oncology, Inc. | -164.95 Million USD | -159.12% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -433.636% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4137.874% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -44529.278% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -9819.517% |
| Autolus Therapeutics plc | -156.77 Million USD | -172.649% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -404.899% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -519.458% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2044.236% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -125.828% |
| GRI Bio, Inc. | -10.89 Million USD | -3822.114% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9365.433% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -248.907% |
| IGM Biosciences, Inc. | -253.35 Million USD | -68.707% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -311.816% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1020.891% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2688.041% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2615.019% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -651.925% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -299.085% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -60.691% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -120.395% |
| Verastem, Inc. | -83.16 Million USD | -413.95% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -745.195% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -170.137% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -274.648% |
| Histogen Inc. | -10.5 Million USD | -3969.618% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2893.282% |
| Surrozen, Inc. | -41.13 Million USD | -939.197% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2786.884% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13328194.793% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -628.0% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -733.298% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1884.456% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5026.31% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -157.387% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -767.733% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1668.733% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2739.129% |
| Apollomics, Inc. | -171.74 Million USD | -148.873% |
| Amarin Corporation plc | -50.9 Million USD | -739.723% |
| Mesoblast Limited | -61.33 Million USD | -596.927% |
| Turnstone Biologics Corp. | -56.23 Million USD | -660.095% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -198.484% |
| Synaptogenix, Inc. | -8.3 Million USD | -5045.13% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2686.57% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -577.958% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8820.694% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 99725.442% |
| Exelixis, Inc. | 196.6 Million USD | 317.41% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1017.119% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -202.266% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 13.687% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3523.639% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 172998.194% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1348.627% |
| Gritstone bio, Inc. | -126.86 Million USD | -236.924% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -557.739% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -10585.944% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3622.951% |
| Insmed Incorporated | -654.73 Million USD | 34.717% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -18899.351% |
| MediWound Ltd. | -4.89 Million USD | -8635.581% |
| OmniAb, Inc. | -49.73 Million USD | -759.488% |
| Alector, Inc. | -142.89 Million USD | -199.129% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -400.307% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -719.652% |
| Zai Lab Limited | -366.57 Million USD | -16.602% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -47.067% |
| Aura Biosciences, Inc. | -83.69 Million USD | -410.696% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -89.76% |
| Immunic, Inc. | -99.11 Million USD | -331.262% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -224.624% |
| Veracyte, Inc. | -49.4 Million USD | -765.089% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -5950.908% |
| FibroGen, Inc. | -261.4 Million USD | -63.513% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3736.568% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6005.013% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2183.673% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 129.49% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1581.347% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1171.527% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1737.67% |
| Galecto, Inc. | -37.51 Million USD | -1039.241% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1017.031% |
| Fortrea Holdings Inc. | 167.3 Million USD | 355.488% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -218.314% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1409.774% |
| XBiotech Inc. | -35.76 Million USD | -1095.079% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -557.739% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -555.068% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -309.202% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1564.974% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -945.91% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 17.237% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -662.985% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -762476.939% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -267.415% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1828.014% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -81.836% |
| NexImmune, Inc. | -28.16 Million USD | -1417.465% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -7635.559% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3524.679% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 109.184% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1583.333% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3549.164% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -239.647% |
| Ainos, Inc. | -8.77 Million USD | -4772.076% |
| Pluri Inc. | -20.22 Million USD | -2013.384% |
| Prothena Corporation plc | -190.1 Million USD | -124.836% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -233.415% |
| Celularity Inc. | -183.94 Million USD | -132.368% |
| Rallybio Corporation | -72.37 Million USD | -490.596% |
| Cue Biopharma, Inc. | -46.05 Million USD | -828.151% |
| MeiraGTx Holdings plc | -57.05 Million USD | -649.197% |
| Omeros Corporation | -163.61 Million USD | -161.251% |
| Humacyte, Inc. | -96.45 Million USD | -343.128% |
| Immunocore Holdings plc | -59.64 Million USD | -616.579% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2106.442% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1654.287% |
| Blueprint Medicines Corporation | -474.61 Million USD | 9.941% |
| CalciMedica, Inc. | -34.18 Million USD | -1150.203% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -483.652% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -240.591% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -153.743% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -69.354% |
| Pulmatrix, Inc. | -12.64 Million USD | -3279.978% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1196.584% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -383.154% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 15.58% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -322.301% |
| Cytokinetics, Incorporated | -456.68 Million USD | 6.405% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1180.772% |
| Nutriband Inc. | -5.12 Million USD | -8245.385% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -887.78% |
| Vor Biopharma Inc. | -114.37 Million USD | -273.724% |
| Roivant Sciences Ltd. | -996.51 Million USD | 57.107% |
| Evogene Ltd. | -23.2 Million USD | -1742.062% |
| ProKidney Corp. | -147.66 Million USD | -189.453% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -562.326% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -278995.521% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 24.411% |
| CorMedix Inc. | -48.88 Million USD | -774.326% |
| BioLineRx Ltd. | -57.06 Million USD | -649.079% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -282.462% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -211500.0% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1077.142% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -437.535% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -425.663% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -55.146% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1290.475% |
| MediciNova, Inc. | -9.87 Million USD | -4226.248% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -239.391% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -27833.062% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1502.744% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -89.977% |
| Biomea Fusion, Inc. | -124.62 Million USD | -242.988% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -29.392% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1540.436% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -124.564% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -85.887% |
| Absci Corporation | -95.45 Million USD | -347.774% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1323.587% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -299.029% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -83.073% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1770.19% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -105.658% |
| Allakos Inc. | -189.91 Million USD | -125.065% |
| Imunon, Inc. | -19.87 Million USD | -2050.247% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -293.976% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 494.587% |
| BioAtla, Inc. | -122.24 Million USD | -249.663% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3523.639% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2611.96% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -42.338% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -931.274% |
| XOMA Corporation | -39.36 Million USD | -985.9% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -330.645% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -263.308% |
| aTyr Pharma, Inc. | -52.17 Million USD | -719.18% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -409.971% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -187.579% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -82.223% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3030.682% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -5214.798% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2443.935% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 226606.841% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 194.576% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6590.516% |
| UroGen Pharma Ltd. | -63.83 Million USD | -569.631% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -529.363% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5785.052% |
| Orgenesis Inc. | -60.71 Million USD | -603.963% |
| Entera Bio Ltd. | -8.8 Million USD | -4754.975% |
| GH Research PLC | -41.15 Million USD | -938.641% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1574.956% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -419.782% |
| Xencor, Inc. | -125.87 Million USD | -239.571% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -29862.742% |
| Replimune Group, Inc. | -230.19 Million USD | -85.68% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2020.449% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3806.343% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6590.516% |
| Portage Biotech Inc. | -18.19 Million USD | -2248.657% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -27833.062% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -308.697% |
| OncoCyte Corporation | -23.12 Million USD | -1748.514% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3682.463% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3630.802% |
| Purple Biotech Ltd. | -22.22 Million USD | -1823.204% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -6568.206% |
| scPharmaceuticals Inc. | -46.06 Million USD | -827.969% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2299.998% |
| HilleVax, Inc. | -132.46 Million USD | -222.673% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3919.863% |
| Tharimmune, Inc. | -9.3 Million USD | -4494.764% |
| Genprex, Inc. | -31.06 Million USD | -1276.124% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -127.932% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1263.246% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -55846.597% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 283347.628% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2714465.788% |
| Savara Inc. | -59.13 Million USD | -622.832% |
| Curis, Inc. | -45.13 Million USD | -846.924% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1292.218% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2713.691% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -5865.555% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1498.833% |
| BeiGene, Ltd. | -1.12 Billion USD | 61.993% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2522.089% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 0.732% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -373.137% |
| Erasca, Inc. | -121.31 Million USD | -252.347% |
| bluebird bio, Inc. | -167.16 Million USD | -155.701% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9401.115% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 237.755% |
| DBV Technologies S.A. | -85.98 Million USD | -397.118% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9401.115% |
| Moderna, Inc. | -3.28 Billion USD | 86.98% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -903.15% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -7467.847% |
| Molecular Templates, Inc. | 1.43 Million USD | 29990.35% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -614.148% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -31.015% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -211.792% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -802.403% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -207.43% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -107.632% |
| MacroGenics, Inc. | 2.01 Million USD | 21291.472% |
| RenovoRx, Inc. | -11.39 Million USD | -3652.695% |
| Adicet Bio, Inc. | -136.53 Million USD | -213.057% |
| Prime Medicine, Inc. | -193.75 Million USD | -120.6% |
| Aditxt, Inc. | -25.45 Million USD | -1578.972% |
| Adagene Inc. | -14.95 Million USD | -2758.927% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5747.145% |
| Quantum-Si incorporated | -91.8 Million USD | -365.592% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 159.998% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 438.011% |
| SciSparc Ltd. | -5.28 Million USD | -7992.238% |
| Vericel Corporation | 2.86 Million USD | 15024.302% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -448845.467% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1870.511% |
| Generation Bio Co. | -133.3 Million USD | -220.654% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -414.792% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -396.881% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -87.937% |
| Invivyd, Inc. | -196.61 Million USD | -117.395% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -14.24% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4508.532% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1674.103% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4055.877% |
| 2seventy bio, Inc. | -206.41 Million USD | -107.071% |
| ADMA Biologics, Inc. | 5.12 Million USD | 8448.281% |
| Clene Inc. | -43.24 Million USD | -888.488% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1757.675% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -781.721% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1502.744% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -42.684% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1063.734% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1913.227% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 8804.884% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1215.904% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -169.837% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 37.538% |
| Evaxion Biotech A/S | -21.4 Million USD | -1897.066% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -543.578% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -96.368% |
| Trevena, Inc. | -35.28 Million USD | -1111.267% |
| Surrozen, Inc. | -41.13 Million USD | -939.197% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -437.029% |
| Cingulate Inc. | -22.95 Million USD | -1762.284% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -5628.884% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1046.453% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5095.876% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -317.961% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -530.18% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -632.255% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4806.998% |
| Kronos Bio, Inc. | -121.83 Million USD | -250.843% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -474.954% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17407.559% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -323.926% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1197.81% |
| ImmunityBio, Inc. | -436.18 Million USD | 2.006% |
| Korro Bio, Inc. | -80.9 Million USD | -428.32% |
| Kineta, Inc. | -15.71 Million USD | -2620.071% |
| BioVie Inc. | -31.95 Million USD | -1237.807% |
| Codexis, Inc. | -49.28 Million USD | -767.301% |
| Celularity Inc. | -183.94 Million USD | -132.368% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -92.963% |
| Celcuity Inc. | -58.3 Million USD | -633.034% |
| Virax Biolabs Group Limited | -6.6 Million USD | -6367.282% |
| Cibus, Inc. | -314.58 Million USD | -35.872% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1167.103% |
| IN8bio, Inc. | -28.5 Million USD | -1399.551% |
| Kodiak Sciences Inc. | -259.02 Million USD | -65.017% |
| Annexon, Inc. | -141.57 Million USD | -201.912% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -279.606% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -565.823% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1429.0% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -85.832% |
| Eyenovia, Inc. | -24.1 Million USD | -1673.133% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1054.43% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -131823.457% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -479.145% |
| Arcellx, Inc. | -64.14 Million USD | -566.353% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -849.553% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -246.166% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1284.081% |
| Moolec Science SA | -52.07 Million USD | -720.792% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -728.26% |
| Geron Corporation | -174.78 Million USD | -144.551% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -957.555% |
| Royalty Pharma plc | 1.88 Billion USD | 122.648% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -257.406% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4484.088% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1960.831% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -157.365% |
| Humacyte, Inc. | -96.45 Million USD | -343.128% |
| Structure Therapeutics Inc. | -102.45 Million USD | -317.174% |
| 89bio, Inc. | -134.46 Million USD | -217.881% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -441.911% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 10648.667% |
| Genelux Corporation | -24.16 Million USD | -1668.806% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1164.592% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -161.484% |
| Notable Labs, Ltd. | -14.4 Million USD | -2868.278% |
| Liquidia Corporation | -70.05 Million USD | -510.173% |
| Mustang Bio, Inc. | -48.06 Million USD | -789.316% |
| Immunovant, Inc. | -269.97 Million USD | -58.321% |
| Quantum-Si incorporated | -91.8 Million USD | -365.592% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -502.136% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2113.756% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -319.002% |
| Acasti Pharma Inc. | -11.3 Million USD | -3682.249% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1820.763% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2688.041% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -103.043% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -9909.313% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2591.637% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1385.377% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1054.286% |
| PepGen Inc. | -83.58 Million USD | -411.392% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1348.726% |
| United Therapeutics Corporation | 1.38 Billion USD | 130.821% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1766.76% |
| Solid Biosciences Inc. | -93.43 Million USD | -357.469% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -8857.579% |
| Immuneering Corporation | -58.06 Million USD | -636.18% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13328194.793% |
| Silo Pharma, Inc. | -3.62 Million USD | -11687.28% |
| Belite Bio, Inc | -31.52 Million USD | -1255.679% |
| XOMA Corporation | -39.36 Million USD | -985.9% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -533.73% |
| Bionomics Limited | -9.83 Million USD | -4245.148% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -408.939% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1135.138% |
| uniQure N.V. | -253.1 Million USD | -68.879% |
| Cassava Sciences, Inc. | -95.68 Million USD | -346.698% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5747.145% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -230.053% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1216.107% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -5209.402% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1414.696% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -131823.457% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3736.568% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2588.083% |
| Altimmune, Inc. | -87.93 Million USD | -386.077% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -364.201% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1135.138% |
| Compugen Ltd. | -12.51 Million USD | -3315.085% |
| Peak Bio, Inc. | -1356.23 USD | -31516088.257% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -779.526% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1800.542% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -76.404% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1397.502% |
| Zura Bio Limited | -60.56 Million USD | -605.764% |
| PolyPid Ltd. | -20.26 Million USD | -2009.421% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2637.667% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1397.502% |
| Instil Bio, Inc. | -146.12 Million USD | -192.517% |
| argenx SE | -216.02 Million USD | -97.864% |
| Immunome, Inc. | -28.27 Million USD | -1411.91% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -781.794% |
| Verona Pharma plc | -52.46 Million USD | -714.659% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -351.011% |
| Shattuck Labs, Inc. | -87.61 Million USD | -387.853% |
| CervoMed Inc. | -2.17 Million USD | -19580.331% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -249.655% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3267.462% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -787.267% |
| Moolec Science SA | -52.07 Million USD | -720.792% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2393.771% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -227.808% |
| AnaptysBio, Inc. | -143.16 Million USD | -198.561% |
| Design Therapeutics, Inc. | -66.32 Million USD | -544.451% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -427.779% |
| NeurAxis, Inc. | -6.66 Million USD | -6313.569% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1032.27% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1068.805% |
| Achilles Therapeutics plc | -70.44 Million USD | -506.786% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -351.011% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1831.108% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 7432.542% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17407.559% |
| Nutriband Inc. | -5.12 Million USD | -8245.385% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -289.467% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -671.093% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -745.563% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -554.797% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -689.933% |
| Palisade Bio, Inc. | -12.28 Million USD | -3380.433% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -841.978% |
| Beam Therapeutics Inc. | -156.47 Million USD | -173.167% |
| Neurogene Inc. | -52.28 Million USD | -717.488% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -213.16% |
| AEON Biopharma, Inc. | -48.36 Million USD | -783.836% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -359.515% |
| Sesen Bio, Inc. | -50.84 Million USD | -740.74% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -421.691% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3360.981% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -306.316% |
| Athira Pharma, Inc. | -116.7 Million USD | -266.256% |
| Vaccinex, Inc. | -19.74 Million USD | -2064.432% |
| HCW Biologics Inc. | -23.57 Million USD | -1712.992% |
| XOMA Corporation | -39.36 Million USD | -985.9% |
| Nektar Therapeutics | -243.1 Million USD | -75.821% |
| Arvinas, Inc. | -394.8 Million USD | -8.265% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 226606.841% |
| Merus N.V. | -149.2 Million USD | -186.469% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -357.195% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1267.345% |
| Rezolute, Inc. | -68.42 Million USD | -524.691% |
| Clene Inc. | -43.24 Million USD | -888.488% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2671.539% |
| BeyondSpring Inc. | -21.54 Million USD | -1884.364% |
| Synlogic, Inc. | -55.16 Million USD | -674.881% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3437.466% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3916.463% |
| Peak Bio, Inc. | -1356.23 USD | -31516088.257% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1216.593% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2487.355% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -260.937% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -25.22% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -9179.026% |
| MannKind Corporation | 15.12 Million USD | 2925.25% |
| Ikena Oncology, Inc. | -74.39 Million USD | -474.529% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3294.203% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2202.78% |
| Gossamer Bio, Inc. | -172.15 Million USD | -148.288% |
| CohBar, Inc. | -12.06 Million USD | -3442.521% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1575.613% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1323.587% |
| Legend Biotech Corporation | -477.87 Million USD | 10.555% |
| Mural Oncology plc | -192.72 Million USD | -121.789% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -274.763% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2547.413% |
| Disc Medicine, Inc. | -91.02 Million USD | -369.576% |
| Champions Oncology, Inc. | -5.05 Million USD | -8357.301% |
| REGENXBIO Inc. | -239.46 Million USD | -78.495% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3887.913% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -666.612% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1002.531% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -278.909% |
| Vaxart, Inc. | -74.72 Million USD | -472.022% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1114.009% |
| Cellectis S.A. | -98.09 Million USD | -335.733% |
| Longeveron Inc. | -20.06 Million USD | -2030.768% |
| Repare Therapeutics Inc. | -114.27 Million USD | -274.045% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 2.679% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -471.341% |
| Revolution Medicines, Inc. | -430.58 Million USD | 0.732% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -6696.502% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1288.262% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -473.042% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 8817.765% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3798.149% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 109.282% |
| Denali Therapeutics Inc. | -179.97 Million USD | -137.498% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -448845.467% |
| Veru Inc. | -89.97 Million USD | -375.053% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1490.267% |
| Cingulate Inc. | -22.95 Million USD | -1762.284% |
| Passage Bio, Inc. | -98.34 Million USD | -334.643% |
| Context Therapeutics Inc. | -25.06 Million USD | -1605.596% |
| Exicure, Inc. | -15.53 Million USD | -2650.705% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -107.427% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1055.971% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -7068.555% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -153.723% |
| Nuvalent, Inc. | -149.49 Million USD | -185.923% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5155.905% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -397.627% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1316.37% |
| OmniAb, Inc. | -49.73 Million USD | -759.488% |
| Anew Medical, Inc. | -1.3 Million USD | -32758.153% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3357.069% |
| Lipocine Inc. | -16.32 Million USD | -2518.641% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -541.116% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -475.255% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1020.891% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -995.586% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1826.845% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 21.582% |
| Ocugen, Inc. | -64.82 Million USD | -559.343% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -361.739% |
| Q32 Bio Inc. | -86.5 Million USD | -394.13% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2425.149% |
| Alumis Inc. Common Stock | -156.89 Million USD | -172.441% |
| Equillium, Inc. | -12.13 Million USD | -3421.437% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -631.003% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5308.239% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2166.224% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -815.429% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -301.93% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2289.679% |
| Dominari Holdings Inc. | -22.44 Million USD | -1804.777% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5118.859% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1582.008% |
| Bio-Techne Corporation | 326.66 Million USD | 230.848% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -11.061% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 297.529% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -226.015% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1041.92% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -182.878% |
| Nkarta, Inc. | -120.48 Million USD | -254.771% |
| BioCardia, Inc. | -11.56 Million USD | -3597.509% |
| Iterum Therapeutics plc | -34.58 Million USD | -1136.067% |